Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by ($0.14), Zacks reports. During the same period in the previous year, the firm posted ($0.24) earnings per share. Acumen Pharmaceuticals Trading Up 3.2 […]

Leave a Reply

Your email address will not be published.

Previous post LCI Industries (NYSE:LCII) to Issue Dividend Increase – $1.15 Per Share
Next post Uruguay October 2024: Fiat (+53.1%) surges ahead in biggest market in 7 years